Printer Friendly

ADVISORY/The Fourth Annual Conference on Regenerative Medicine; Rebuilding the Body, Restoring Function.

News Editors

ADVISORY...for Monday-Wednesday (Nov. 17-Nov. 19)

LARCHMONT, N.Y.--(BUSINESS WIRE)--Oct. 27, 2003

At the Renaissance Washington, D. C. Hotel on November 17-19, leading researchers, scientists, physicians, and entrepreneurs in cellular therapies, Alzheimer's disease, tissue engineering, new ventures, and substitutive medicine: organ replacement and repair will share the latest advances in the provocative new field of Regenerative Medicine. Regenerative Medicine, a unique new approach to healing that uses the body's own genes, proteins, antibodies, and cells to repair organs and tissues.


 What: The Fourth Annual Conference on Regenerative Medicine:
 Rebuilding the Body, Restoring Function

 When: November 17-19, 2003, opening Monday, Nov. 17, at 5:00 p.m.;
 concluding Wednesday, Nov. 19, at 5:00 p.m.

 Where: Renaissance Washington, D.C. Hotel, 999 Ninth Street N.W.,
 Washington, D.C.

 Who: William A. Haseltine, Ph.D., Chairman & CEO, Human Genome
 Sciences, Inc., conference chair, will present opening remarks
 and an overview November 17, at 5:00 p.m. on Regenerative
 Medicine: Rebuilding the Body, Restoring Function.
 Robert S. Langer, Ph.D., Kenneth J. Germeshausen, Professor of
 Chemical and Biomedical Engineering, MIT will present a
 keynote address November 17, at 6:00 p.m. on Novel
 Biomaterials.

 Topics: Cellular Therapies: Repairing the Damaged and Worn Body
 Session Chair: Professor Ian Wilmut, Roslin Institute
 -Stem Cell Medicine Encounters the Immune System: Strategies
 for Avoiding Rejection
 -The Derivation and Value of Hematopoietic Side Population
 Cells: Therapeutic Applications
 -Purified Hematopoietic Stem Cells and the Induction of Immune
 Tolerance
 -Nuclear Transfer as a Source of Cells for Therapy: Two
 Methods for Producing Immunologically Matched Cells

 Exploring New Frontiers in Alzheimer's Disease
 Session Chair: Michael Wolfe, Ph.D., Associate Professor,
 Center for Neurologic Diseases, Brigham and Women's Hospital,
 Harvard Medical School
 -Subtle Differences in Protein Quantity Underlie Initiation of
 Neurodegenerative Diseases
 -Drug and Gene Delivery to the Brain: The Trans-Vascular Route
 -Secretase Targets for Alzheimer's Disease
 -Beta Amyloid Immunization Therapy

 Tissue Engineering Supervisory Session Chair: Anthony Atala, M.D.,
 Director, Laboratory for Cellular Therapeutics and Tissue
 Engineering/Professor of Surgery, Children's Hospital Boston/
 Harvard Medical School
 Session Chair: Robert M. Nerem, Ph.D., Director, Parker H.
 Petit Institute for Bioengineering & Bioscience,Georgia
 Institute of Technology
 -Regenerative Medicine: The Need for a National Initiative
 -A Systems Approach to the Tissue Engineering of Heart Muscle
 -Realizing the Potential of Cell Encapsulation: How to Make it
 Work
 -Tissue Engineering, Stem Cells, and Cloning: Current Concepts
 and Changing Trends

 New Ventures Address Linda Powers, Managing Director, Toucan
 Capital

 Substitutive Medicine: Organ Replacement and Repair Session Chair:
 Peer M. Portner, Ph.D., Consulting Professor of Cardiothoracic
 Surgery,Stanford University School of Medicine
 -Heart Failure: Replacement, Repair, or Regeneration
 -Myocardial Repair: Stem Cells to the Rescue
 -Blood Substitutes and Artificial Cells: Today and Tomorrow
 -Artificial Lung: From ECMO to Bioartificial Implant

 Donald W. Fink, Jr., Ph.D., Cellular, Tissue and Gene Therapies,
 Center for Biologics Evaluation and Research, FDA, will speak
 Wednesday, November 19, from noon to 1:00 p.m. at the
 luncheon.

 Sponsors: USF College of Medicine, Regenerative Medicine and Stem
 Cell Biology www.mmsionline.com/regmed and Genetic Engineering
 News www.genengnews.com

 Supporters: Human Genome Sciences, Inc., Toucan Capital Corp.

 Details: For complete program and registration visit:
 http://www.bioconferences.com/ebio

 Press Conference: Tuesday, November 18 at 10:30 a.m. Room 15

COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 27, 2003
Words:549
Previous Article:American Medical Alert Corp. Announces Exclusive PERS Agreement with Scan Health Plan.
Next Article:Bigfoot Interactive Hosts ``PROfile Email Summit 2003;'' First Summit of Industry Experts Assembled to Discuss the Amended S. 877 - Burns/Wyden CAN...


Related Articles
ADVISORY/The Fourth Annual Conference on Regenerative Medicine to be Held November 17-19 in Washington, D.C.
ADVISORY/The Fourth Annual Conference on Regenerative Medicine Rebuilding the Body, Restoring Function.
ADVISORY/The Fourth Annual Conference on Regenerative Medicine; Rebuilding the Body, Restoring Function.
ADVISORY/The Fourth Annual Conference on Regenerative Medicine; Rebuilding the Body, Restoring Function.
ADVISORY/The Fourth Annual Conference on Regenerative Medicine; Rebuilding the Body, Restoring Function.
Medicine for the third millennium: an historical perspective.
Making a muscle: engineered fibers grow in the lab and in mice.
BREAST RECONSTRUCTION STUDY INITIATED IN JAPAN.
Home Chiropractic Handbook.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters